Exhibit 99.1

 

 

 

Stratasys Releases Fourth Quarter and Full Year 2022 Financial Results

 

Fourth quarter revenue of $159.3 million, 4.6% lower versus fourth quarter 2021 but up 1.7% at constant currency and adjusted for divestitures

 

Fourth quarter GAAP net loss of $2.4 million, or $0.04 per diluted share, and non-GAAP net income of $4.6 million, or $0.07 per diluted share

 

Full year revenue of $651.5 million, 7.3% higher versus 2021 and up 11.4% at constant currency and adjusted for divestitures

 

Full year GAAP net loss of $29.0 million, or $0.44 per diluted share, and non-GAAP net income of $10.3 million, or $0.15 per diluted share

 

$327.8 million cash and equivalents and no debt at year end 2022

 

MINNEAPOLIS & REHOVOT, Israel - (BUSINESS WIRE) - March 2, 2023 - Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced financial results for the fourth quarter and full year 2022.

 

Dr. Yoav Zeif, Stratasys’ Chief Executive Officer stated, “Stratasys grew 11.4% in 2022, adjusting for divestitures and currency impacts, while delivering our sixth consecutive quarter of profitability on an adjusted basis against an increasingly challenging macroeconomic environment. Strong execution by our team and a relentless focus on controlling costs contributed to our effective efforts to overcome these challenges.”

 

Dr. Zeif continued, “We are encouraged by the strong future demand indicators from our customers for our additive manufacturing polymer systems and consumables. Our high engagement levels across our innovative products, along with the strength of our customer service revenues, provide us with the confidence that once capital spending restrictions are lifted and utilization levels increase, our efforts will be rewarded. With our broad-based technology portfolio and an unmatched go-to-market capability, we are positioned well to gain increased share when macroeconomic headwinds subside. Armed with a strong balance sheet and a disciplined approach to capital allocation, we are well prepared to build on our industry leadership in the coming years.”

 

Summary - Fourth Quarter 2022 Financial Results Compared to Fourth Quarter 2021:

 

Revenue of $159.3 million compared to $167.0 million.

 

GAAP gross margin of 43.1%, compared to 43.7%.

 

Non-GAAP gross margin of 48.4%, compared to 48.7%.

 

GAAP operating income of $1.6 million, compared to an operating loss of $16.2 million.

 

Non-GAAP operating income of $5.1 million, compared to non-GAAP operating income of $1.7 million.

 

GAAP net loss of $2.4 million, or $0.04 per diluted share, compared to a net loss of $4.8 million, or $0.07 per diluted share.

 

Non-GAAP net income of $4.6 million, or $0.07 per diluted share, compared to non-GAAP net income of $0.5 million, or $0.01 per diluted share.

 

Adjusted EBITDA of $10.7 million, compared to $7.9 million.

 

Planned inventory build resulted in cash used in operations of $18.1 million, compared to cash generated of $4.4 million year over year.

 

 

 

 

 

 

Summary - 2022 Financial Results Compared to 2021:

 

Revenue of $651.5 million compared to $607.2 million.

 

GAAP gross margin of 42.4%, compared to 42.8%.

 

Non-GAAP gross margin of 48.0%, compared to 47.8%.

 

GAAP operating loss of $57.2 million, compared to a $79.2 million operating loss.

 

Non-GAAP operating income of $13.5 million, compared to a $1.7 million non-GAAP operating loss.

 

Adjusted EBITDA of $36.1 million, compared to $22.6 million.

 

GAAP net loss of $29.0 million, or ($0.44) per diluted share, compared to a loss of $62.0 million, or ($0.98) per diluted share.

 

Non-GAAP net income of $10.3 million, or $0.15 per diluted share, compared to non-GAAP net loss of $4.3 million, or $(0.07) per diluted share.

 

Planned inventory build resulted in cash used in operations of $75.4 million, compared to cash provided by operations of $35.8 million.

 

Non-GAAP Adjustments:

 

   Quarter Ended
December 31,
   Year Ended
December 31,
 
Revenue Growth Rates (%) as reported   (4.6)%   7.3%
Adjusted Revenue Growth Rates (%) excluding divestitures   (0.3)%   9.0%
Adjusted Revenue Growth Rates (%) excluding divestitures and FX effects   1.7%   11.4%

 

Financial Outlook:

 

Based on current market conditions and assuming that the impacts of global inflationary pressures, interest rate hikes and supply chain costs do not impede economic activity further, the Company is providing the following outlook for 2023:

 

Full year revenue of $620 million to $670 million.

 

Sequential quarterly revenue growth, notably higher in the second half

 

Based on current logistics and materials costs, full year gross margins of 48.0% to 49.0%, with improved year-over-year growth in the second half of 2023.

 

Full year-operating expenses of $290 million to $300 million.

 

Full year non-GAAP operating margins of 2.5% to 3.5% with improving profitable contribution through the year.

 

2

 

 

 

 

GAAP net loss of $78 million to $57 million, or ($1.12) to ($0.83) per diluted share.

 

Non-GAAP net income of $9 million to $17 million, or $0.12 to $0.24 per diluted share.

 

Adjusted EBITDA of $35 million to $50 million.

 

Capital expenditures of $20 million to $25 million.

 

Non-GAAP earnings guidance excludes $30 million to $32 million of projected amortization of intangible assets, $28 million to $30 million of share-based compensation expense, and reorganization and other expenses of $15 million to $22 million. Non-GAAP guidance includes tax adjustments of $2 million to $3 million on the above non-GAAP items.

 

Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

 

Stratasys Ltd. Fourth Quarter 2022 Webcast and Conference Call Details

 

The Company plans to webcast its conference call to discuss its fourth quarter 2022 financial results on Thursday, March 2, 2023, at 8:30 a.m. (ET).

 

The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:

 

https://event.choruscall.com/mediaframe/webcast.html?webcastid=K6UFH5he

 

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

 

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

 

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

 

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

 

3

 

 

 

 

Cautionary Statement Regarding Forward-Looking Statements

 

The statements in this press release regarding Stratasys’ strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2023 and beyond, are forward-looking statements reflecting management’s current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys’ business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the global macro-economic environment, including headwinds caused by inflation, rising interest rates, unfavorable currency exchange rates and potential recessionary conditions, potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others’ intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2022, which we are filing with the U.S. Securities and Exchange Commission, or SEC, on or about March 2, 2023 (the “2022 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2022 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2023, which will be furnished to the SEC throughout 2023, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Use of Non-GAAP Financial Measures

 

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

 

Yonah Lloyd

 

CCO, VP Investor Relations

 

Yonah.Lloyd@stratasys.com

 

Source: Stratasys Ltd.

 

4

 

 

Stratasys Ltd.

 

Consolidated Balance Sheets

(in thousands, except share data)

 

 

   December 31,   December 31, 
   2022   2021 
         
ASSETS        
         
Current assets        
Cash and cash equivalents  $150,470   $243,179 
Short-term deposits   177,367    259,000 
Accounts receivable, net of allowance for credit losses of $0.9 million and $0.5 million as of December 31, 2022 and December 31, 2021   144,739    129,382 
Inventories   194,054    129,147 
Prepaid expenses   5,767    6,871 
Other current assets   27,823    33,123 
           
Total current assets   700,220    800,702 
           
Non-current assets          
Property, plant and equipment, net   195,063    203,295 
Goodwill   64,953    65,144 
Other intangible assets, net   121,402    152,244 
Operating lease right-of-use assets   18,122    14,651 
Long-term investments   141,610    28,667 
Other non-current assets   18,420    12,519 
           
Total non-current assets   559,570    476,520 
           
Total assets  $1,259,790   $1,277,222 
           
LIABILITIES AND EQUITY          
           
Current liabilities          
Accounts payable  $72,921   $51,976 
Accrued expenses and other current liabilities   45,912    55,358 
Accrued compensation and related benefits   34,432    44,684 
Deferred revenues - short term   50,220    51,174 
Operating lease liabilities - short term   7,169    7,276 
           
Total current liabilities   210,654    210,468 
           
Non-current liabilities          
Deferred revenues - long term   25,214    21,133 
Deferred income taxes - long term   5,638    7,341 
Operating lease liabilities - long term   10,670    7,693 
Contingent consideration - long term   23,707    53,478 
Other non-current liabilities   24,475    21,095 
           
Total non-current liabilities   89,704    110,740 
           
Total liabilities   300,358    321,208 
           
Equity          
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 67,086 thousands shares and 65,677 thousands shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively   187    182 
Additional paid-in capital   3,048,915    3,012,481 
Accumulated other comprehensive loss   (12,818)   (8,771)
Accumulated deficit   (2,076,852)   (2,047,878)
Total equity   959,432    956,014 
           
Total liabilities and equity  $1,259,790   $1,277,222 

 

5

 

 

Stratasys Ltd.

 

Consolidated Statements of Operations

(in thousands, except per share data)

 

 

   Three Months Ended December 31,   Twelve Ended December 31, 
   2022   2021   2022   2021 
   (unaudited)   (unaudited)         
Net sales                
Products  $111,197   $118,040   $452,124   $417,557 
Services   48,062    48,976    199,359    189,662 
    159,259    167,016    651,483    607,219 
                     
Cost of sales                    
Products   58,180    59,470    234,601    210,941 
Services   32,431    34,503    140,415    136,200 
    90,611    93,973    375,016    347,141 
                     
Gross profit   68,648    73,043    276,467    260,078 
                     
Operating expenses                    
Research and development, net   21,387    22,620    92,876    88,303 
Selling, general and administrative   45,665    66,584    240,750    250,937 
    67,052    89,204    333,626    339,240 
                     
Operating loss   1,596    (16,161)   (57,159)   (79,162)
                     
Gain from deconsolidation of subsidiary   -    -    39,136    - 
Gain from step acquisition   -    14,400    -    14,400 
Financial income (expense), net   2,309    (692)   229    (2,075)
                     
Income (loss) before income taxes   3,905    (2,453)   (17,794)   (66,837)
                     
Income tax benefit (expense)   (2,658)   (2,103)   (5,454)   3,906 
                     
Share in profit (losses) of associated companies   (3,637)   (280)   (5,726)   949 
                     
Net income (loss)  $(2,390)  $(4,836)  $(28,974)  $(61,982)
                     
Net income (loss) per share                    
Basic  $(0.04)  $(0.07)  $(0.44)  $(0.98)
Diluted  $(0.04)  $(0.07)  $(0.44)  $(0.98)
                     
Weighted average ordinary shares outstanding                    
Basic   66,908    65,196    66,491    63,471 
Diluted   66,908    65,196    66,491    63,471 

 

6

 

 

   Three Months Ended December 31, 
   2022   Non-GAAP   2022   2021   Non-GAAP   2021 
   GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP 
   U.S. dollars and shares in thousands (except per share amounts) 
Gross profit (1)  $68,648   $8,423   $77,071   $73,043   $8,255   $81,298 
Operating income (loss) (1,2)   1,596    3,456    5,052    (16,161)   17,822    1,661 
Net income (loss) (1,2,3)   (2,390)   6,940    4,550    (4,836)   5,355    519 
Net income (loss) per diluted share (4)  $(0.04)  $0.11   $0.07   $0.07   $0.08   $0.01 
Acquired intangible assets amortization expense        7,297              6,024      
Non-cash stock-based compensation expense        1,041              866      
Restructuring and other related costs        85              1,185      
Impairment charges        -              180      
         8,423              8,255      
                               
Acquired intangible assets amortization expense        2,370              2,280      
Non-cash stock-based compensation expense        7,664              6,971      
Restructuring and other related costs        874              373      
Revaluation of investments        560              (1,861)     
Contingent consideration        (19,490)             (20)     
Other expenses        3,056              1,824      
         (4,967)             9,568      
         3,456              17,822      
                               
Corresponding tax effect        1,770              1,906      
Equity method related amortization, divestments and impairments        1,714              27      
Gain from obtaining control        -              (14,400)     
        $6,940             $5,355      
                               
Weighted average number of ordinary shares outstanding - Diluted   66,908         67,231    65,196         66,820 

 

7

 

 

   Twelve Months Ended December 31, 
   2022   Non-GAAP   2022   2021   Non-GAAP   2021 
   GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP 
   U.S. dollars and shares in thousands (except per share amounts) 
Gross profit (1)  $276,467   $36,016   $312,483   $260,078   $30,447   $290,525 
Operating income (loss) (1,2)   (57,159)   70,691    13,532    (79,162)   77,479    (1,683)
Net income (loss) (1,2,3)   (28,974)   39,235    10,261    (61,982)   57,639    (4,343)
Net income (loss) per diluted share (4)  $(0.44)  $0.59   $0.15   $(0.98)  $0.91   $(0.07)
                               
Acquired intangible assets amortization expense        28,158              22,392      
Non-cash stock-based compensation expense        4,082              3,093      
Restructuring and other related costs        (174)             1,642      
Impairment charges        3,949              3,320      
         36,016              30,447      
                               
Acquired intangible assets amortization expense        8,950              8,878      
Non-cash stock-based compensation expense        29,378              27,885      
Impairment of long-lived assets        -              1,447      
Restructuring and other related costs        2,737              2,743      
Revaluation of investments        3,777              (1,303)     
Contingent consideration        (18,293)             570      
Other expenses        8,126              6,812      
         34,676              47,032      
         70,691              77,479      
                               
Corresponding tax effect        4,988              (864)     
Equity method related amortization, divestments and impairments        2,285              (4,576)     
Finance expenses        406              -      
Gain from deconsolidation of subsidiary        (39,136)             -      
Gain from obtaining control        -              (14,400)     
                               
        $39,235             $57,639      
                               
Weighted average number of ordinary shares outstanding - Diluted   66,491         67,068    63,471         63,471 

 

8

 

 

Stratasys Ltd.

 

Reconciliation of GAAP to Non-GAAP Forward Looking Guidance

Fiscal Year 2023

(in millions, except per share data)

 

 

GAAP net loss   ($78) to ($57)
    
Adjustments   
Stock-based compensation expense  $28 to $30
Intangible assets amortization expense  $30 to $32
Reorganization and other  $15 to $22
Tax expense (benefit) related to Non-GAAP adjustments  $2 to $3
    
Non-GAAP net income   $9 to $17
    
GAAP loss per share   ($1.12) to ($0.83)
    
Non-GAAP diluted earnings per share  $0.12 to $0.24

 

 

9